Introduction: Platinum-etoposide (PE) chemotherapy (CH) is a globally established combination for EP-G3-NEC; the optimal schedule has not been established.
Aim(s): The aim was to explore which PE CH schedules are in use across centres, to assess consistency in clinical practice.
Materials and methods: An international survey was designed, and completed by clinicians with an expertise in the field.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Medical treatment - Chemotherapy Somatostatin analogues, Interferon
Presenting Author: Dr Angela Lamarca
To read results and conclusion, please login ...
Further abstracts you may be interested in